You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for LOMAIRA


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for LOMAIRA

Average Pharmacy Cost for LOMAIRA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LOMAIRA 8 MG TABLET 10702-0001-09 0.56483 EACH 2024-12-18
LOMAIRA 8 MG TABLET 10702-0001-09 0.56501 EACH 2024-11-20
LOMAIRA 8 MG TABLET 10702-0001-09 0.56632 EACH 2024-10-23
LOMAIRA 8 MG TABLET 10702-0001-09 0.56602 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Lomaira

Introduction to Lomaira

Lomaira, also known as phentermine, is a prescription weight loss medication that belongs to the class of sympathomimetic amines. It is used as an adjunct to a reduced-calorie diet and increased physical activity for weight loss in adults with a BMI of 30 or higher, or those with a BMI of 27 or higher in the presence of at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.

Market Context of Anti-Obesity Drugs

The global anti-obesity drugs market has been growing rapidly, driven by increasing obesity rates and the need for effective weight loss treatments. In 2017, the global anti-obesity drugs market was valued at $1.3 billion and was expected to grow at a CAGR of 29.1% from 2017 to 2022. Prescription drugs dominated this market, holding 96% of the global share[1].

Mechanism of Action of Lomaira

Lomaira works by stimulating the hypothalamus gland and affecting certain neurotransmitters to decrease appetite. It is a short-term weight loss drug, typically prescribed for a few weeks to a few months, although it can be used for longer durations under medical supervision[3].

Market Position and Sales

Lomaira is one of the several phentermine-based drugs available in the market. It is available in a lower dosage strength of 8 mg compared to other phentermine products like Adipex-P, which is available in 37.5 mg tablets. This lower dosage can make Lomaira a more appealing option for patients who need a milder effect or have certain health conditions that preclude the use of higher doses[3].

Pricing and Cost Analysis

The cost of Lomaira without insurance can vary based on several factors, including the pharmacy, location, and any available discounts. Here are some approximate costs:

  • Generic Phentermine: While Lomaira is a specific brand, generic phentermine can cost between $8-$25 for a 30-day supply of 37.5 mg tablets. However, Lomaira, being a brand-name drug with a lower dosage (8 mg), can cost around $21-$41 for a 30-count[3].
  • Brand-Name Lomaira: Without insurance, Lomaira can cost between $21-$41 for a month’s supply of 8 mg tablets. This price range can vary depending on the pharmacy and location[3].

Insurance Coverage

Insurance coverage for Lomaira can significantly reduce the out-of-pocket costs. However, many insurance plans, including Medicare Part D, may not cover weight loss medications like phentermine due to their classification. If covered, the cost can be as low as $0 or $1 per monthly prescription, depending on the insurance provider and the plan’s formulary[3].

Market Forecasts and Trends

The anti-obesity drugs market is expected to continue growing, driven by the increasing prevalence of obesity and the demand for effective weight loss treatments. Here are some key trends and forecasts:

  • Global Market Growth: The global anti-obesity drugs market is projected to grow significantly, with various mechanisms of action, including sympathomimetics like Lomaira, contributing to this growth[1].
  • Prescription vs. OTC: Prescription drugs, which include Lomaira, are expected to dominate the market, with a significant market share due to their efficacy and regulatory approval[1].
  • Regional Markets: The US market is a significant segment of the global anti-obesity drugs market, and drugs like Lomaira are expected to see continued demand in this region[1].

Key Takeaways

  • Market Growth: The anti-obesity drugs market is growing rapidly, driven by increasing obesity rates.
  • Pricing: Lomaira costs between $21-$41 for a 30-day supply without insurance, but costs can be significantly lower with insurance coverage.
  • Mechanism of Action: Lomaira works by stimulating the hypothalamus gland to decrease appetite.
  • Market Position: Lomaira is a brand-name phentermine product with a lower dosage strength, making it a unique offering in the market.

FAQs

1. What is Lomaira used for? Lomaira is used as an adjunct to a reduced-calorie diet and increased physical activity for weight loss in adults with a BMI of 30 or higher, or those with a BMI of 27 or higher in the presence of at least one weight-related condition.

2. How much does Lomaira cost without insurance? Lomaira can cost between $21-$41 for a 30-day supply of 8 mg tablets without insurance.

3. Is Lomaira covered by insurance? Many insurance plans, including Medicare Part D, may not cover Lomaira. However, if covered, the cost can be significantly reduced.

4. How does Lomaira work? Lomaira works by stimulating the hypothalamus gland and affecting certain neurotransmitters to decrease appetite.

5. What are the potential side effects of Lomaira? Common side effects include dry mouth, dizziness, insomnia, and constipation. Serious side effects can include heart problems and allergic reactions.

Sources

  1. Visiongain: Global Anti-Obesity Drugs Market Forecast 2018-2028.
  2. Ro: How Much Does Phentermine Cost With and Without Insurance?
  3. Ro: How Much Does Phentermine Cost With and Without Insurance?

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.